Predictive genomics is a powerful capability to help predict disease risk and understand drug responses to improve health outcomes and manage costs. Powerful and complex research infrastructures are needed to fill the knowledge gap in developing and implementing predictive genomics, including biobanks, data infrastructures, ELSI, and top-in-class genotyping.
Qatar is among the pioneering countries in the region, with predictive genomics and precision medicine at the heart of its health strategy. The Qatar Genome Program (QGP) is a national program that has contributed to sequencing more than 28,000 whole genomes from the Qatar population and over 2,900 whole genomes from 19 other Arab countries collected by Qatar Biobank. The QBB/QGP data is the most important existing genomic data on the Arab and Middle Eastern regions. It contributes to understanding of the genetic structure of these populations, elucidating the genetic factors of various diseases, and laying the groundwork for precision medicine in the region.
In this webinar, Radja Messai-Badji shares her experience within QGP and providese her opinion on the key elements necessary to build a state-of-the-art predictive genomics program. She discusses the main obstacles at the scientific, technical, ELSI, and organizational levels that have faced the program and how QGP is working on overcoming such barriers.
- Understand the potential of predictive genomics performed with microarray
- Describe the infrastructure ecosystem necessary to deliver large predictive genomics programs
- How Qatar Biobank is laying the ground for precision medicine in the Arab and Middle Eastern regions
Operations Manager, Qatar Genome Program, Qatar Foundation, Qatar
Please fill out the short form below to view this on-demand webinar.